AKT1 and allergic disease: Phosphatidylinositol 3-kinase/protein kinase B (PI3K–PKB), including upstream regulatory molecules, downstream targets, antagonists of various receptors, and inhibition of intracellular signaling factors, etc., these may become potential therapeutic drugs for allergic diseases [4, 5].